Dr. Midhun Malla, MD

Dr. Malla practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Malla's NPI, 1265865968, was assigned on August 16, 2013. Dr. Malla holds Alabama license 46618.

Dr. Malla's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Malla's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Malla is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Malla to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malla practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Malla's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Malla's licenses on file in 3 states: Alabama, Arizona and Oklahoma.

CMS data shows 225 Medicare services from Dr. Malla across 3 procedure codes in 2024, for 53 Medicare patients. Medicare paid $14,270 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Malla in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malla's median patient age at 66, with 48% women.

In 2024, Dr. Malla wrote 220 Medicare Part D claims for 59 patients. 87% of them were for generic drugs. CMS names the drug for 86 of them, across 5 drugs with 11 or more claims each, at $1,961 in total drug cost. In 2023, CMS named 196 claims across 7 drugs.

Dr. Malla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malla as offering telehealth.

Dmand AI links 23 papers to Dr. Malla, published from 2015 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Biomarkers, Tumor, Circulating Tumor DNA and Colorectal Neoplasms. Dr. Malla has published most often in Cureus. Dr. Malla's most frequent co-authors are Aparna Raj Parikh, MD, Brijesh Patel, MD and Bassel Fouad El-Rayes, MD.

Dmand AI links Dr. Malla to 5 clinical trials, 5 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Anal Canal Carcinoma, Gallbladder Neoplasms and Non functioning pancreatic endocrine tumor. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 202 general payments to Dr. Malla from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Incyte Corporation paid the most, $72,049.